Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2009, Mission BioCapital is a life science venture capital firm based in San Francisco, California, and Cambridge, Massachusetts. The firm operates its fifth fund and manages a portfolio of 10 companies, focusing on early-stage investments in the life sciences sector.
Mission BioCapital invests in early-stage life science companies, targeting pre-seed, seed, seed-plus, and Series A stages. Their investment areas include therapeutics, drug delivery, and lab tools, with a strong emphasis on mentorship and collaboration with founders.
Notable portfolio companies include Caribou Biosciences, which exited with an IPO in July 2021; Alector, which had a successful IPO in February 2019; and Pionyr Immunotherapeutics, which exited in 2020. Other active investments include Zag Bio, Symbiome, and PanTher Therapeutics.
Submit your pitch through their form at this link.
Mission BioCapital focuses on early-stage life science companies, providing capital and mentorship to help accelerate their development from discovery to clinical application.
Yes, Mission BioCapital often leads investment rounds, particularly in the pre-seed and seed stages, to support the growth of their portfolio companies.
The firm is currently operating its fifth fund, although specific fund size details are not disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.